Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco van Vulpen

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 10, 2010
Influence of dose on risk of acute urinary retention after iodine-125 prostate brachytherapyEllen M A Roeloffzen, Jan J Battermann, Marijke J H van Deursen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapyKarel A Hinnen, Jan J Battermann, Joep G H van Roermund, et al.
Medical Physics|October 27, 2016
Fiber Bragg gratings-based sensing for real-time needle tracking during MR-guided brachytherapyMaxence Borot de Battisti, Baudouin Denis de Senneville, Metha Maenhout, et al.
BJU International|March 5, 2017
Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancerAbi Kanthabalan, Max Peters, Marco Van Vulpen, et al.
The Journal of Urology|February 24, 2009
Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapySteven J Frank, Lawrence B Levy, Deborah A Kuban, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Influence of antiflatulent dietary advice on intrafraction motion for prostate cancer radiotherapyIrene M Lips, Alexis N T J Kotte, Carla H van Gils, et al.
Magnetic Resonance in Medicine|May 24, 2011
Phase-based arterial input function measurements in the femoral arteries for quantification of dynamic contrast-enhanced (DCE) MRI and comparison with DCE-CTJohannes G Korporaal, Cornelis A T van den Berg, Matthias J P van Osch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 2, 2010
Validation of functional imaging with pathology for tumor delineation in the prostateGreetje Groenendaal, Maaike R Moman, Johannes G Korporaal, et al.
BJU International|June 13, 2009
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapyJoep G H van Roermund, Karel A Hinnen, Jan J Battermann, et al.
Anticancer Research|September 27, 2015
Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical ResectionElisabeth A Kastelijn, Sherif Y El Sharouni, Frederik N Hofman, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|July 10, 2010
Influence of dose on risk of acute urinary retention after iodine-125 prostate brachytherapyEllen M A Roeloffzen, Jan J Battermann, Marijke J H van Deursen, et al.
International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapyKarel A Hinnen, Jan J Battermann, Joep G H van Roermund, et al.
Medical Physics|October 27, 2016
Fiber Bragg gratings-based sensing for real-time needle tracking during MR-guided brachytherapyMaxence Borot de Battisti, Baudouin Denis de Senneville, Metha Maenhout, et al.
BJU International|March 5, 2017
Focal salvage high-intensity focused ultrasound in radiorecurrent prostate cancerAbi Kanthabalan, Max Peters, Marco Van Vulpen, et al.
The Journal of Urology|February 24, 2009
Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapySteven J Frank, Lawrence B Levy, Deborah A Kuban, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Influence of antiflatulent dietary advice on intrafraction motion for prostate cancer radiotherapyIrene M Lips, Alexis N T J Kotte, Carla H van Gils, et al.
Magnetic Resonance in Medicine|May 24, 2011
Phase-based arterial input function measurements in the femoral arteries for quantification of dynamic contrast-enhanced (DCE) MRI and comparison with DCE-CTJohannes G Korporaal, Cornelis A T van den Berg, Matthias J P van Osch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 2, 2010
Validation of functional imaging with pathology for tumor delineation in the prostateGreetje Groenendaal, Maaike R Moman, Johannes G Korporaal, et al.
BJU International|June 13, 2009
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapyJoep G H van Roermund, Karel A Hinnen, Jan J Battermann, et al.
Anticancer Research|September 27, 2015
Clinical Outcomes in Early-stage NSCLC Treated with Stereotactic Body Radiotherapy Versus Surgical ResectionElisabeth A Kastelijn, Sherif Y El Sharouni, Frederik N Hofman, et al.
Pageof 15